PARP1-dependent DNA-protein crosslink repair

DNA-protein crosslinks (DPCs) are toxic lesions that inhibit DNA related processes. Post-translational modifications (PTMs), including SUMOylation and ubiquitylation, play a central role in DPC resolution, but whether other PTMs are also involved remains elusive. Here, we identify a DPC repair pathway orchestrated by poly-ADP-ribosylation (PARylation). Using Xenopus egg extracts, we show that DPCs on single-stranded DNA gaps can be targeted for degradation via a replication-independent mechanism. During this process, DPCs are initially PARylated by PARP1 and subsequently ubiquitylated and degraded by the proteasome. Notably, PARP1-mediated DPC resolution is required for resolving topoisomerase 1-DNA cleavage complexes (TOP1ccs) induced by camptothecin. Using the Flp-nick system, we further reveal that in the absence of PARP1 activity, the TOP1cc-like lesion persists and induces replisome disassembly when encountered by a DNA replication fork. In summary, our work uncovers a PARP1-mediated DPC repair pathway that may underlie the synergistic toxicity between TOP1 poisons and PARP inhibitors.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2024-08-05
DOI
https://doi.org/10.1038/s41467-024-50912-x
Citations
21
Primary Topic
PARP inhibition in cancer therapy
Type
article
Field-Weighted Citation Impact
5.93

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PARP1-dependent DNA-protein crosslink repair

Marta Oliva-Santiago, Jesper Q. Svejstrup, Michael L. Nielsen, Julien P. Duxin et al.
21 citations
Nature Communications
PARP inhibition in cancer therapy
5.93
article

PARP1-dependent DNA-protein crosslink repair

Marta Oliva-Santiago, Jesper Q. Svejstrup, Michael L. Nielsen, Julien P. Duxin, Ulrike Kühbacher, Ivo A. Hendriks, A. Barbara Dirac-Svejstrup, Keith W. Caldecott, Zita Fábián, Nicolai Balle Larsen, Ellen S. Kakulidis, Junhui Wang, Xueyuan Leng
article en
21 citations

Abstract

DNA-protein crosslinks (DPCs) are toxic lesions that inhibit DNA related processes. Post-translational modifications (PTMs), including SUMOylation and ubiquitylation, play a central role in DPC resolution, but whether other PTMs are also involved remains elusive. Here, we identify a DPC repair pathway orchestrated by poly-ADP-ribosylation (PARylation). Using Xenopus egg extracts, we show that DPCs on single-stranded DNA gaps can be targeted for degradation via a replication-independent mechanism. During this process, DPCs are initially PARylated by PARP1 and subsequently ubiquitylated and degraded by the proteasome. Notably, PARP1-mediated DPC resolution is required for resolving topoisomerase 1-DNA cleavage complexes (TOP1ccs) induced by camptothecin. Using the Flp-nick system, we further reveal that in the absence of PARP1 activity, the TOP1cc-like lesion persists and induces replisome disassembly when encountered by a DNA replication fork. In summary, our work uncovers a PARP1-mediated DPC repair pathway that may underlie the synergistic toxicity between TOP1 poisons and PARP inhibitors.

Nature CommunicationsVol. 15(1)
University of Copenhagen (DK), University of Sussex (GB), Novo Nordisk Foundation (DK)
European Commission, Novo Nordisk, Novo Nordisk Fonden, Medical Research Council
Openalex Percentile: Top 3%
PARP inhibition in cancer therapy
5.93
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.